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Why the move to microfluidics for protein analysis?
Niels Lion1, Fre´de´ric Reymond2, Hubert H Girault1 and Joe¨l S Rossier2
There has been a recent trend towards the miniaturization of
analytical tools, but what are the advantages of microfluidic
devices and when is their use appropriate? Recent advances in
the field of micro-analytical systems can be classified according
to instrument performance (which refers here to the desired
property of the analytical tool of interest) and two important
features specifically related to miniaturisation, namely reduction
of the sample volume and the time-to-result. Here we discuss the
contribution of these different parameters and aim to highlight
the factors of choice in the development and use of microfluidic
devices dedicated to protein analysis.
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Abbreviations
CE capillary electrophoresis
2D-GE two-dimensional gel electrophoresis
ECD electron capture dissociation
ESI-MS electrospray ionization mass spectrometry
MALDI-MS matrix-assisted laser desorption ionization mass
spectrometry
MS mass spectrometry
SPE solid phase extraction
Introduction
Microfluidic (bio)analytical devices have received much
interest over the past 15 years, mainly because of the
advent of large-scale biology, namely genomics and pro-
teomics. These requirements include extreme sensitivity
and reproducibility, high-throughput and the need to
derive a wide variety of relevant structural or biochemical
information (see [1] for further details and an extensive
review on protein microsystems). The motivations for
turning from macroscale analytical procedures to micro-
analytical devices is variously defined in the literature as a
low sample consumption, fast analysis times and high-
throughput potentialities, the possibility of integration
and automation, and the desire for single-use devices
associated with the suppression of cross-contamination.
These four major driving forces are rarely precisely
defined, however, and the purpose of this review is to
further understanding of the benefits that can be obtained
from miniaturization. In particular, decreased sample
volume and time reduction are not always attainable
simultaneously, or even desirable, although this is
claimed to be the case by many authors. Why move
towards the use of microfluidic bio-analytical devices
and which technical solutions should be adopted for a
particular problem? We propose to tackle these questions
by analysis of the analytical triangle: performance (i.e. the
desired analytical performance which is a prerequisite of
any analytical tool), sample volume and time-to-result,
which are more intrinsically linked to microfluidics.
Recent examples from the literature are analyzed in
the light of this triangle, with a special focus on protein
microfluidic systems (microarrays are not discussed here).
The analytical triangle
Performance refers herein to the expected result, depend-
ing on the particular problem to be solved. As such,
performance is a function of different parameters, for
example, detection limit, selectivity, reproducibility, the
ability to repeat an assay, analysis time and sample volume.
Depending on the application, the analytical platform will
not seek the same performance. Reduction of sample
volume and, often, reduction of the time-to-result are
intrinsically linked to miniaturization. In the choice of
an analytical platform, it is therefore compulsory to under-
stand how these two parameters impact the performance of
the entire platform. For this reason, these two items are
explicitly differentiated in the present report.
The case for sample volume is quite obvious, and it may
always seem desirable to reduce the sample volume as far
as possible to save precious chemicals or to limit clinical
sampling (e.g. for the analysis of cerebrospinal fluid or for
neo-natal testing). However, in the case of in vitro diag-
nostics, a few milliliters of blood are usually withdrawn for
sampling, so reducing the sample size to submicroliters is
unlikely to be the major driving force in the development
of a miniaturized assay. On the contrary, minimizing the
amount of sample may be the primary goal of assay
development in some instances; for example, in the case
of in vivo glucose sensing, where diabetic patients are
tested several times a day, to reduce sampling pain
Therasense Inc. developed a portable sensor that samples
volumes as small as 0.3 ml [2].
The other factor that is generally emphasized in the
miniaturization of analytical tools is the reduction of time
taken to obtain the result (time-to-result). The principle
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here is also quite simple and argues that two molecules
placed in a large volume will take more time to contact
each other (and further react) than if placed in a very
small, confined environment. This feature does not
change the kinetics of the reaction, but reduces the mass
transport time from typically 1 h in the mesoscale world
(microtiterplate well) to a few seconds in a microchannel
with a typical dimension of 50 mm. The same philosophy
can be applied to separation, where a smaller scale
reduces the separation time. (It should be stressed here
that one should not confuse time-to-result with high-
throughput, which can be achieved by parallelization of
most of the analytical processes.) To further illustrate
the concept of this analytical triangle, Figure 1 deline-
ates how a microtiter plate, a microarray and a micro-
fluidic immunoassay would compare to reach the
performance desired in the different assays: the micro-
titer plate deals with large amounts of sample (in the
milliliter range) and requires relatively long incubation
times (in the hour range). Comparatively, the microarray
is incubated with a few tens of microliters for a relatively
long time, whereas the microfluidic immunoassay
requires only a few microliters of sample and is com-
pleted in a few minutes [3].
The impact of the sample volume and time-to-result on
the performance of a micro-analytical system is discussed
in more detail below, with reference to recent advances in
microfluidics.
Sample volume reduction
When thinking of microfluidics, the first feature to come
to mind is small volumes. The outstanding surface-to-
volume ratio of microchannels (typically 80 000 m1 com-
pared with 500 m1 for a microtiter plate well) allows
elution of samples in incomparably small volumes after
capture on a solid-phase extraction (SPE) sorbent [4,5] (see
Figure 2). Yu et al. further increased the intrinsically high
surface-to-volume ratio of their microfluidic device by
incorporating a monolith within the microchannel [6];
by eluting green fluorescent protein in a very small volume
they were able to reach 1000-fold preconcentration [7].
In some analyses only very small volumes of samples are
directly available, or samples might come from an
upstream sample preparation step that resulted in a
Figure 1
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A comparison of the different bioanalytical tools in the framework of the
analytical triangle: performance, time-to-result and sample volume.
An immunoassay in a microtiter plate requires several hours with a
relatively large amount of sample (purple surface in the graph), a
microarray requires less sample, but a relatively long incubation time
(pink surface in the graph), and a microfluidic immunoassay deals with
small volumes and is completed in a few minutes (yellow surface in the
graph). This figure shows an example of each of the above-described
analytical platforms, namely (from left to right) a polystyrene microtiter
plate from Beckman Coulter Inc. (Fullerton, USA), a microdot array from
Haab et al. [46], and a polyimide microchip with integrated gold
electrodes from DiagnoSwiss SA (Monthey, Switzerland).
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SPE microdevice for protein digest analysis. (a) Isometric projection of
the packed bed used for SPE and capillary electrochromatography
(CEC) illustrating the 1 mm deep weirs used to trap the bead bed.
The volume of the chamber is 330 pL, which enables preconcentration
of extremely small sample volumes. (b) Elution trace of 1 pM of a
fluorescent dye, BODIPY (S/N ¼ 45) and 10 pM BODIPY (S/N ¼ 434),
obtained after concentration for 3 min from pH 8.3 aqueous buffer from
the SPE bed depicted in (a). Elution was performed with 40%
acetonitrile/60% pH 8.3 buffer. (Figure reproduced from [5] with
permission.)
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concentrated small volume. Thus, miniaturization ap-
pears as a valuable alternative to dilution, which would
be necessary to analyze the sample in the macro-world.
Scaling down an analytical process poses technical pro-
blems, however, and these have been reviewed from a
general view point by Madou and Cubicciotti [8]. Match-
ing sample volume and the sensitivity of the chosen
detection technique is a crucial point that is further
discussed by Lion et al. [1] in the context of protein
analysis and proteomics. It is not the scope of this paper to
enter into the specificities of each detection technique,
and the reader is referred to these two reviews for further
details. Nevertheless, miniaturization of analytical tools
has been undertaken for many years without microfab-
rication technologies. The development of pulled capil-
lary nanospray emitters for peptide and protein analysis
by electrospray ionization mass spectrometry (ESI-MS)
allowed the routine analysis of a few microliters [9].
These devices are now being microfabricated with tech-
nologies imported from the microelectronics industry to
improve reproducibility and robustness of the system.
Many technological approaches have been based on
polymer [10–13] and glass or silicon [14,15] microfabrica-
tion, among them are mature devices working either with
robotic stations such as the NanomateTM system from
Advion Biosciences [16] or stand-alone disposable
devices [17]. This kind of micro- or nanospray micro-
fabricated emitter is appearing at a time when exciting
developments in mass spectrometry are starting to
emerge, such as new methodologies based on the cap-
abilities of MS for the structural elucidation of protein
complexes or complex mixture analysis. For example,
Kalkum et al. [18] recently introduced a methodology
called ‘hypothesis-driven multistage mass spectrometry’
to assess the presence of particular compounds in a
mixture: peptides of an expected mass are very selec-
tively isolated by tandem mass spectrometry (MS/MS)
and their identification further confirmed by MS/MS/MS
(where the third mass stage is used to fragment the
isolated molecules and further confirm their identity).
No previous separation is required. Using this approach,
more than one hundred secreted peptides were inter-
rogated in a single MS experiment from direct cell culture
supernatant. Although the proof-of-principle for this
methodology was presented with matrix-assisted laser
desorption ionization MS (MALDI-MS), there is no
fundamental reason why it could not be extended to
ESI-MS. Similarly, Emmett [19] presented MS/MS/
MS developments in Fourier transform ion cyclotron
resonance MS (FTICR-MS) for the elucidation of the
glycosylation structure on proteins separated by two-
dimensional gel electrophoresis (2D-GE). Different
fragmentation processes, namely electron capture disso-
ciation (ECD) and infrared multiphoton dissociation
(IRMPD), were combined to obtain complementary
information about tryptic peptide sequences and carbo-
hydrate structure.
These two examples are typical of the progress made in
MS technology during the past few years: more and more
information can be gathered during a single experiment
at the cost of analysis time. Most of these technologies
cannot be operated at the pace of a liquid chromato-
graph, so it is necessary to handle small samples (typi-
cally less than 2 ml) during long analysis times with
reliable possibilities of re-interrogation (which implies
better robustness and reproducibility than current
nanospray needles). For this kind of methodology,
microchips (e.g. thin polymer infusion microtips [17])
seem a particularly valuable option, as they can combine
small sample volumes with high-performance results
and flexible experimental times.
One issue when dealing with small volumes is reprodu-
cibility: even if 1–2 ml can easily be handled manually,
microfluidics can help satisfactory reproducibility to be
obtained in complex sample preparation. Gyros devel-
oped a compact disc (CD)-like platform to prepare pep-
tide digests for MALDI-MS: samples are moved along
the sample preparation chain just by rotating the CD.
The samples undergo adsorption on a reverse-phase
followed by washing out of salts, mixing with the matrix
and finally co-crystallization in the outlets of the device.
The integration of all steps leads to a very reproducible
results [20].
Microfluidics has also been incorporated into BIAcoreTM
instruments for measuring surface plasmon resonance,
mainly to take advantage of the very well-controlled mass
transport phenomena that occur in microdimensions [21],
but also limit sample consumption. (It should be noted,
however, that surface plasmon resonance is sensitive only
to the quantity of mass adsorbed at the surface, not to the
concentration of the sample, so downsizing poses sensi-
tivity problems). Microfluidics also allows a controlled
recovery of captured analytes for further characterization,
for example, by MS [22,23]. For a given sample volume,
microsystems can thus increase the performance of an
analytical platform by improving the quality and variety
of information that can be delivered per assay.
Time-to-result decrease
It was soon recognized that miniaturization could directly
result in a speeding-up of analytical processes, culminat-
ing in a report by Jacobson et al. [24] in which submilli-
second separation of fluorescent dyes was achieved by
on-chip capillary electrophoresis. In the proteomics anal-
ytical chain, one of the first limiting steps is proteolysis,
which typically requires anything from 4–12 h. Peterson
et al. [25] presented a microfluidic system with embedded
trypsin immobilized on a monolith, which could reach a
sample throughput of one protein digested and analyzed
by on-line ESI-MS per minute (see Update). Protein and
peptide mixtures must be separated to obtain protein
identification within such mixtures. Transfer of capillary
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gel electrophoresis (CGE) into microfluidic format has
also been accomplished by Bousse et al. [26], allowing
complete separations within a few minutes. Over the past
three years Ramsey’s laboratory have pioneered on-chip
multidimensional separations [27,28,29], finally achiev-
ing protein digest separations within 15 min with an
impressive peak capacity of 4200 (as shown in
Figure 3). These separations were accomplished with
fluorescent detection only, and allowed the discrimina-
tion of bovine and human hemoglobin based on protein
digestion fingerprinting.
The coupling of microchips with ESI-MS discussed pre-
viously can also result in a decrease in time-to-result: by
integration of robotics for sample delivery to the micro-
fabricated electrospray emitter and nozzle-to-nozzle
reproducibility provided by microfabrication, the ESI-
ChipTM from Advion Biosciences provides new tools
for MS screening. For instance, Kapron et al. [30] identi-
fied and quantified small drugs directly from human
plasma with very limited sample preparation at a rate
of 60 samples per hour. Likewise, van Pelt et al. [31]
demonstrated the screening of drug permeation proper-
ties from Caco-2 cell tests with an analysis rate of 45 sec-
onds per sample. In both of these examples the new MS
microchip allowed complete suppression of a liquid chro-
matography step and, as such, the time-to-result delay
was greatly reduced. From the above-mentioned exam-
ples of the use of MS microchips, it can be seen that they
can be used either for their intrinsically small sample
volume or for reduced time-to-results. In fact, this con-
sideration has a strong impact on the design of the
microchip: whereas the integration of one hundred ESI
emitters on the same chip with automated sample deliv-
ery results in high-throughput capabilities, its cost pre-
vents its use where reduced sample volume without the
need for high-throughput is the driving force for minia-
turization.
Another field where the time-to-result is crucial is that
of clinical immunoassay: several approaches have been
presented, such as homogeneous immunoassays with
antibody–antigen complex detection and quantification
by capillary electrophoresis (CE) and laser-induced
fluorescence or electrochemical means [32,33]. By con-
trast, heterogeneous immunoassays replace CE with a
washing step and have been demonstrated on microchip
platforms [34,35–40]. The key advantage of microflui-
dics in this case is to bring antibodies and antigens in
such close proximity that diffusion is no longer a limiting
factor: Rossier et al. [41] showed that depletion of the
whole microchannel volume occurred in less than 5 min.
Moreover, heterogeneous immunoassays allow the con-
centration of captured antigen by flowing the sample
solution over the antibody bed in an efficient fashion.
Picomolar sensitivity with electrochemical detection,
fast analysis times of less than 15 min for the whole
immunoassay, and mass production possibilities make
this kind of microfluidic immunoassay a very promising
tool in diagnostics and protein analysis. In reference to
Figure 3
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Two-dimensional separation of a protein digest on a chip by micellar electrokinetic chromatography (MEKC) and capillary electrophoresis (CE),
which reached a 4200 peak capacity within 15 min. (Figure reproduced from [27] with permission.)
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the above-mentioned analytical triangle the scheme
presented in Figure 1 for the microchip-based immu-
noassay shows that this kind of analytical platform meets
best with the requirements of clinical diagnostics. In this
domain, the specific features of miniaturization have
many advantages, but efforts still need to be made in
the industrialization of global microfluidic immunoassay
platforms before market implementation.
All these efforts to minimize the volume and time-to-
result have resulted in some integrated platforms for
protein analysis [42]. One of the most successful to date
has been provided by Li et al. [43] who presented the
SPE of tryptic digests from 2D-GE followed by CE and
infusion to ESI-MS. The design of the device and the
scheme of operation are shown in Figure 4. The set-up
provided an analysis rate of 12 samples per hour.
Microfluidics in real life
As briefly presented above, and more extensively
reviewed elsewhere [1,44], many demonstrations of
the potentialities of miniaturization for protein analysis
have been provided. However, the driving forces for
miniaturization are not always clearly outlined, which
makes it difficult for potential end-users to identify a
clear benefit for their particular application. Although
benefits are quite clear in some fields, such as diagnos-
tics where time-to-result can be a matter of survival as
for D-Dimer testing [34], in many other fields micro-
fluidics has not yet been identified as a clear break-
through. For example, most proteomic or screening
laboratories rely on old technologies such as 2D-GE
[45] and perceive microfluidics as a disruptive technol-
ogy that aims to replace all traditional analytical meth-
ods. Instead, we believe that microfluidics offers some
clear advantages for some analytical applications where
very limited amounts of sample are available or where
time-to-result is critical. It is probable that clear clinical
examples will appear soon, as with the analysis of 2 ml of
cerebrospinal fluid on a chip, which is hardly feasible
with conventional tools.
One should only turn to microfluidics, however, when
there is a clear benefit for doing so, because these new
technologies are not so easy to operate, often expensive
and constitute a change in habits of personnel. It is our
Figure 4
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Integrated platforms for protein analysis. (a) Scheme of the device proposed by Li et al. [43] for SPE-CE-MS of tryptic digests and (b) the scheme
of operation. This device was used for the unattended identification of 72 proteins from a human prostatic cancer cell line LNCap at a rate of 12
samples per hour. (Figure reproduced from [43] with permission.)
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belief that customers and end-users will continue to
segment the microfluidics domain by choosing the types
of device that are beneficial for them and that will remain
smart academic demonstrations of know-how.
Update
Peterson et al. [47] recently presented a dual-function
microfluidic device for on-line tryptic digestion on a
40 nL trypsin bed and preconcentration of peptides on
a 10 nL SPE bed. In all experiments, protein digestion
was completed in 1 min, and peptides further desalted
and concentrated on the SPE bed. No further throughput
improvement was obtained from previous studies, but
results quality was greatly improved in terms of sequence
coverage thanks to the concentration step.
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